Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
Health Secretary highlights the need for capacity building programmes for Medical Officers to tackle Non Communicable Diseases at the primary level
Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology
Continues to Expand its Presence in South India
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Subscribe To Our Newsletter & Stay Updated
